Capricor Therapeutics (CAPR) Current Leases (2021 - 2025)
Historic Current Leases for Capricor Therapeutics (CAPR) over the last 5 years, with Q3 2025 value amounting to $120094.0.
- Capricor Therapeutics' Current Leases fell 8523.98% to $120094.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $120094.0, marking a year-over-year decrease of 8523.98%. This contributed to the annual value of $834799.0 for FY2024, which is 1143.85% up from last year.
- Latest data reveals that Capricor Therapeutics reported Current Leases of $120094.0 as of Q3 2025, which was down 8523.98% from $849505.0 recorded in Q2 2025.
- Capricor Therapeutics' Current Leases' 5-year high stood at $849505.0 during Q2 2025, with a 5-year trough of $120094.0 in Q3 2025.
- Its 5-year average for Current Leases is $673710.4, with a median of $718496.0 in 2023.
- In the last 5 years, Capricor Therapeutics' Current Leases soared by 6331.1% in 2022 and then crashed by 8523.98% in 2025.
- Capricor Therapeutics' Current Leases (Quarter) stood at $417632.0 in 2021, then skyrocketed by 63.31% to $682039.0 in 2022, then grew by 9.83% to $749112.0 in 2023, then grew by 11.44% to $834799.0 in 2024, then crashed by 85.61% to $120094.0 in 2025.
- Its Current Leases stands at $120094.0 for Q3 2025, versus $849505.0 for Q2 2025 and $842101.0 for Q1 2025.